Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The utility of MRI in suspected MS [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Open access
Frohman, E. M., Goodin, D. S., Calabresi, P. A., Corboy, J. R., Coyle, P. K., Filippi, M., Frank, J. A., Galetta, S. L., Grossman, R. I., Hawker, K., Kachuck, N. J., Levin, M. C., Phillips, J. T., Racke, M. K., Rivera, V. M., Stuart, W. H. · 2003 · Neurology

Abstract

Advancements in imaging technologies and newly evolving treatments offer the promise of more effective management strategies for MS. Until recently, confirmation of the diagnosis of MS has generally required the demonstration of clinical activity that is disseminated in both time and space. Nevertheless, with the advent of MRI techniques, occult disease activity can be demonstrated in 50 to 80% of patients at the time of the first clinical presentation. Prospective studies have shown that the presence of such lesions predicts future conversion to clinically definite (CD) MS. Indeed, in a young to middle-aged adult with a clinically isolated syndrome (CIS), once alternative diagnoses are excluded at baseline, the finding of three or more white matter lesions on a T2-weighted MRI scan (especially if one of these lesions is located in the periventricular region) is a very sensitive predictor (>80%) of the subsequent development of CDMS within the next 7 to 10 years. Moreover, the presence of two or more gadolinium (Gd)-enhancing lesions at baseline and the appearance of either new T2 lesions or new Gd enhancement on follow-up scans are also highly predictive of the subsequent development of CDMS in the near term. By contrast, normal results on MRI at the time of clinical presentation makes the future development of CDMS considerably less likely.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000082654.99838.ef

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 189

Metadata

Authors
Frohman, E. M., Goodin, D. S., Calabresi, P. A., Corboy, J. R., Coyle, P. K., Filippi, M., Frank, J. A., Galetta, S. L., Grossman, R. I., Hawker, K., Kachuck, N. J., Levin, M. C., Phillips, J. T., Racke, M. K., Rivera, V. M., & Stuart, W. H.
Venue
Neurology
Published
2003-09-09
Volume
61
Issue
5
Pages
602-611
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2089634785
Cited by
189
References
6
FWCI
15.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The utility of MRI in suspected MS [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. https://app.cochat.ai/papers/10.1212/01.wnl.0000082654.99838.ef
The paper
Frohman, E. M., Goodin, D. S., Calabresi, P. A., Corboy, J. R., Coyle, P. K., Filippi, M., Frank, J. A., Galetta, S. L., Grossman, R. I., Hawker, K., Kachuck, N. J., Levin, M. C., Phillips, J. T., Racke, M. K., Rivera, V. M., & Stuart, W. H. (2003). The utility of MRI in suspected MS [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. https://doi.org/10.1212/01.wnl.0000082654.99838.ef

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.